Medivir AB (publ) (LON:0GP7)
London · Delayed Price · Currency is GBP · Price in SEK 0.5500
-0.0200 (-3.51%)
At close: Oct 29, 2025
Medivir AB Market Cap
Medivir AB has a market cap or net worth of 3.92 million as of November 18, 2025. Its market cap has decreased by -83.02% in one year.
Market Cap
3.92M
Enterprise Value
2.57M
Revenue
314.54K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.55
Market Cap Chart
Since April 30, 1999, Medivir AB's market cap has decreased from 47.34M to 3.92M, a decrease of -91.72%. That is a compound annual growth rate of -8.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 3.92M | -83.00% |
| Dec 30, 2024 | 23.05M | 86.09% |
| Dec 29, 2023 | 12.39M | -71.80% |
| Dec 30, 2022 | 43.92M | -14.08% |
| Dec 30, 2021 | 51.12M | 182.66% |
| Dec 30, 2020 | 18.09M | -26.47% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 72.30B |
| Haleon | 32.91B |
| Smith & Nephew | 10.56B |
| ConvaTec Group | 4.70B |
| Hikma Pharmaceuticals | 3.49B |
| HUTCHMED (China) | 1.97B |
| Genus | 1.63B |